The translocator protein (TSPO) (18 kDa) is an emerging drug target for the treatment of numerous pathologies including cancer and neurodegenerative disease. However, our limited knowledge of TSPO binding site(s) has hindered the development of TSPO ligands with potential therapeutic effects. We have synthesized a series of pyrrolobenzoxazepines (1-10) to better characterize the interaction of ligands with the TSPO across species, and to determine their functional profiles.

Evidence for complex binding profiles and species differences at the translocator protein (TSPO) (18 kDa) / AM Scarf; C Luus; E Da Pozzo; S Selleri; C Guarino; C Martini; LM Ittner; M Kassiou.. - In: CURRENT MOLECULAR MEDICINE. - ISSN 1566-5240. - ELETTRONICO. - 12:(2012), pp. 488-493.

Evidence for complex binding profiles and species differences at the translocator protein (TSPO) (18 kDa).

SELLERI, SILVIA;
2012

Abstract

The translocator protein (TSPO) (18 kDa) is an emerging drug target for the treatment of numerous pathologies including cancer and neurodegenerative disease. However, our limited knowledge of TSPO binding site(s) has hindered the development of TSPO ligands with potential therapeutic effects. We have synthesized a series of pyrrolobenzoxazepines (1-10) to better characterize the interaction of ligands with the TSPO across species, and to determine their functional profiles.
2012
12
488
493
AM Scarf; C Luus; E Da Pozzo; S Selleri; C Guarino; C Martini; LM Ittner; M Kassiou.
File in questo prodotto:
File Dimensione Formato  
Evidenceforcomplex_CMM2012.pdf

accesso aperto

Tipologia: Pdf editoriale (Version of record)
Licenza: Open Access
Dimensione 423.3 kB
Formato Adobe PDF
423.3 kB Adobe PDF

I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificatore per citare o creare un link a questa risorsa: https://hdl.handle.net/2158/862710
Citazioni
  • ???jsp.display-item.citation.pmc??? ND
  • Scopus 20
  • ???jsp.display-item.citation.isi??? 20
social impact